This distribution partnership and registration within Saudi Arabia allows Palette to establish a beachhead within the Middle East, and is an excellent starting point to ensure long-term access to our innovative products for customers and patients in the region” James Leech, Palette Life Sciences

SANTA BARBARA, Calif. and STOCKHOLM (PRWEB)
July 14, 2020

Palette Life Sciences, a fully integrated global life sciences company dedicated to improving patient outcomes, today announced its latest distribution agreement with Gulf Horizon Co. Ltd. (GHIM). GHIM will distribute Palette’s product, Deflux, in Saudi Arabia. GHIM is a medical equipment company that provides hospitals with innovative medical devices for minimally invasive surgery in the Kingdom of Saudi Arabia (KSA). This new distribution agreement with GHIM further extends Palette’s global expansion efforts, and marks the first time Deflux has been directly registered within the KSA.

“This distribution partnership and registration within Saudi Arabia allows Palette to establish a beachhead within the Middle East, and is an excellent starting point to ensure long-term access to our innovative products for customers and patients within the region,” said James Leech, Head of Corporate Development, Palette Life Sciences. “GHIM has vast experience and deep physician relationships within the KSA. We are confident that GHIM will be an excellent partner to aid in our delivery of high quality solutions to physicians and patients. Palette Life Sciences is dedicated to supporting physicians globally in their pursuit of improved patient outcomes. Palette and its network of partners are making several significant investments within local markets to improve physician access to Palette resources, including renewed product training and support.“

For more information or to place an order within a GHIM territory, please contact a GHIM representative at jamil@ghim-sa.com.

About Deflux

Deflux is a minimally invasive, outpatient treatment that has been proven safe and effective in children with vesicoureteral reflux (VUR). VUR is a serious paediatric urinary condition in which urine refluxes from the bladder through one or both ureters toward the kidneys, due to an abnormality at the junction of the ureter and the bladder. Deflux is an injectable gel bulking agent made from two tissue-friendly polysaccharides; Non-Animal Stabilised Hyaluronic Acid (NASHA®) and dextranomer (Dx) microspheres. The product is administered via injection around the ureteral opening to prevent urine reflux. Deflux is indicated for children with all VUR grades and is the recommended first-line treatment for VUR.1 Separate study results show Deflux is an efficacious long-term (15 – 25 years) treatment option for VUR grade IV2 with up to 93% success rates after a one time injection and no post-injection febrile UTIs (19 month results).3 Deflux is the only minimally invasive VUR treatment approved globally across Australia, Canada, Europe, Latin American, Japan, New Zealand and the United States.

About Palette Life Sciences AB

Palette Life Sciences is a fully integrated life sciences company. Palette’s products improve patient outcomes in urology and urogynecology disorders, colorectal conditions, radiotherapy, and interventional oncology procedures. The company’s portfolio of available products includes Deflux®, Solesta® and Barrigel®. Palette Life Sciences moves rapidly to leverage novel applications of existing technologies to create breakthrough medical solutions. This focus enables the company to serve those often overlooked by traditional medical companies and improve patient quality of life. Led by experienced healthcare executives, Palette Life Sciences is headquartered in Stockholm, Sweden, with offices in Santa Barbara, California, and Dallas, Texas. Learn more at http://www.palettelifesciences.com.

References:

1. Elder JS, Shah MB, Batiste LR, Eaddy M. Part 3: Endoscopic injection versus antibiotic prophylaxis in the reduction of urinary tract infection in patients with vesicoureteral reflux. Curr Med Res Opin. 2007;23(4):S15-20.

2. Stenbäck A, Olafsdottir T, Sköldenberg E, Barker G, Läckgren G. Non-animal hyaluronic acid/dextranomer gel (Deflux®) endoscopic treatment in grade IV VUR results after 15-25 years: durable and effective. J Pediatr Urol. 2020.

3. Kalisvaart JF, Scherz HC, Cuda S, Kaye JD, Kirsch AJ. Intermediate to long-term follow-up indicates low risk of recurrence after Double HIT endoscopic treatment for primary vesicoureteral reflux. J Pediatr Urol. 2012;9(4)359-365.

Q-Med AB is the current legal manufacturer and holds the CE Mark.

Deflux®, GHIM®, NASHA®, and Palette Life Sciences™ are registered trademarks.

All rights reserved. APM209A

Share article on social media or email:

The proud team at Quince Orchard Dental Care!

“Quince Orchard Dental Care’s main goal was to cater to 10,000 patients by 2020. Words cannot express how proud my team and I are, to be able to achieve this goal in 2019.” – Dr. Mehran Rouhanian, Owner of Quince Orchard Dental Care

GAITHERSBURG, Md. (PRWEB)
July 14, 2020

Quince Orchard Dental Care is a complete health practice, which means they consider your overall health in everything they do. The mouth is the gateway to the body and oral health problems are usually indicators that your overall health may be in jeopardy. Their team of dentists works closely with patients – both adults and children and their general physicians to achieve optimal overall health.

The practice’s main mission is to make people healthy. Dr. Rouhanian, owner of Quince Orchard Dental Care, and his experienced team set out to help 10,000 people be on the road to great health by 2020. To aid this effort, they moved to a new location with more space, state-of-the-art equipment, and a bigger, highly qualified team. They also participated in community outreach programs, school visits, word of mouth, etc and were able to make a positive impact on the community. They are very pleased to announce that their dream has now become a reality. The 10,000 healthy patients milestone has been reached before 2020! Their daily efforts have paid off and they look forward to 10,000 more patients!

“Quince Orchard Dental Care takes pride in being able to improve the oral health of everyone in our community by providing quality dental care services from experienced professionals. One of our main goals was to cater to 10,000 patients by 2020. Words cannot express how proud my team and I are to be able to achieve this goal in 2019.” – Dr. Mehran Rouhanian, Owner of Quince Orchard Dental Care

The achievement of such a monumental milestone has caught a lot of positive attention from their community and patients. In honor of their accomplishment, they’ve snagged the front cover of an issue of the Discover The Best Of Montgomery County. There is also an article featured where you can read more about what this accomplishment means to Quince Orchard Dental Care.

Pride is always taken in the meticulous care provided to patients and as such 10,000 patients trusted Quince Orchard Dental Care with their oral health. The practice’s skills, expertise, and professionalism are delivered in a personalized, comfortable atmosphere of empathy and mutual trust. Their dentists and support staff are dedicated to their continued education and professional development. Professional self-improvement goals, adding innovative and new techniques, and procuring the latest in technological advances in the dental industry are key contributors to their team’s excellence. Ultimately, this represents their commitment to administering world-class service to their valued patients.

At Quince Orchard Dental Care, patients are never rushed. Instead, they are provided with attentive consultations that allow for the dentists to delve a little deeper and provide education about proper dental care as well as their patients’ overall health. The wait for appointments is kept to a minimum while ensuring that other patients are not rushed. Timeliness and attentiveness are cornerstones of everything they do. For these reasons and more, you are invited to check them out, where maybe for the first time, you will start enjoying visits to the dentist. Schedule an appointment with them to become the first set of the next 10,000 patients to be on the road to great health as well!

Share article on social media or email:

Living Rare Living Stronger Virtual Forum – July 18-19 2020

“During this time, we have learned that the success of virtual education events requires both the underlying technology that provides an engaging, interactive experience for attendees, as well as a team of seasoned program and production experts to support online event execution.”

BOSTON (PRWEB)
July 13, 2020

PlatformQ Health is proud to be supporting the National Organization for Rare Disorder’s (NORD) annual Living Rare, Living Stronger Patient and Family Forum. During this challenging time, when communities are coping with the repercussions of the COVID-19 crisis, including the impact on live, in-person conferences, PlatformQ Health is uniquely positioned to help NORD pivot to a live, virtual conference through use of their Conduit platform.

PlatformQ has been a pioneer in the field of live, video-based education for more than 10 years. Robert Rosenbloom, CEO of PlatformQ Health shares, “During this time, we have learned that the success of virtual education events requires both the underlying technology that provides an engaging, interactive experience for attendees, as well as a team of seasoned program and production experts to support online event execution.”

In 2019 PlatformQ Healthand NORD established a partnership to provide online Continuing Medical Education for clinicians as well as tailored education for patients and caregivers. Together, NORD and PlatformQ Health target resources to health care professionals, patients, and families to facilitate timely diagnosis and improved care for people with rare disorders. The virtual Living Rare, Living Stronger event provides an opportunity to expand the pair’s collaboration to support the rare community.    

In addition to tracks for newly diagnosed patients, advanced patients, and caregivers, this year’s event includes engaging workshops for medical professionals and students. Topics include Gene Therapy for Rare Diseases, Caring for Rare Disease Patients in Your Practice, and Current Trends and Opportunities in Rare Disease Research: What Every Physician Should Know about Research. Speakers include medical and research professionals from The National Institutes of Health, PCORI and leading medical institutions from around the country.

This year’s Living Rare Forum will include engaging digital sessions along with interactive Q&As and inspiring online panels presented by patients, caregivers, and top rare disease medical experts. Katie Kowalski, NORD’s Associate Director for Education, shared, “We are thrilled to have a partner that is just as excited as we are to provide the rare disease community with meaningful education, networking opportunities, inspiration, hope and fun!”

Together, PlatformQ Health and NORD will provide patients and families with up-to-date and meaningful education about living their best lives with rare diseases while simultaneously preparing physicians and medical students about how to treat and care for their patients.

Be sure to explore the virtual conference on July 18th and 19th!

Recent PQH and NORD Digital Education Collaborations for Patients and HCPS

PlatformQ Health and NORD have partnered to design and distribute disease-specific and general rare disease education, leverage top medical specialists from NORD’s foundation and patient organization members, and incorporate the patient voice in HCP education. Educational activities launched over the last year that are currently available to watch on-demand include:

Most recently, PlatformQ Health and NORD launched the aligned educational program, Overview on Hemophilia A Management for Clinicians and Patients: A Joint CME & Patient Educational Initiative, which includes a dedicated patient education session and a CME activity for health care professionals. These two sessions share similar learning objectives related to treatment and overall care to help break down communication barriers between patient and clinicians, facilitating shared decision making.

The patient education portion of this initiative,A Closer Look at Hemophilia Management: Improving Outcomes with Personalized Care, aired on RareDiseaseLive and OMedLive in early June and is now available to watch on-demand. This is an interactive, expert-led HCP-patient-family educational activity that was developed to offer clarity and guidance, as top experts answered questions that patients and families had regarding their treatment and overall care.

The CME portion of this program titled, Optimizing Prophylaxis Strategies of Hemophilia, A with or without Inhibitors: For Whom, When, and How Long? aired Thursday June 15th on OMedLive. HCPs can watch top experts, Steven W. Pipe, MD, Stacy E. Croteau, MD, MMS and Kelly Tickle, MSN, APN, PPCNP-BC, PCNS-BC, CWON via streaming video, get the latest medical science and earn AMA PRA Category 1 Credit™. The program is now available to watch on-demand.

Another new aligned educational program will be available this summer – Spinal Muscular Atrophy: A New Era for Both Patients and Clinicians. The CME activity, Post-Treatment SMA Phenotypes and Multidisciplinary Care will air on July 13th at 12pm EST on NeuroSeriesLive. The patient educational program, Obtaining Support and Ongoing Care for Children with SMA after Gene Replacement Therapy, will be available in August. Keep your eye out for more information and updates regarding this important and timely tethered educational activity.

About the National Organization for Rare Disorders (NORD®)

The National Organization for Rare Disorders (NORD) is the leading independent advocacy organization representing all patients and families affected by rare diseases. NORD is committed to the identification, treatment and cure of more than 7,000 rare diseases, of which approximately 90% are still without an FDA-approved treatment or therapy. Rare diseases affect over 25 million Americans. More than half of those affected are children.

NORD began as a small group of patient advocates that formed a coalition to unify and mobilize support to pass the Orphan Drug Act of 1983. For 37 years, NORD has led the way in voicing the needs of the rare disease community, driving supportive policies and education, advancing medical research and providing patient and family services for those who need them most. NORD is made strong together with over 300 disease-specific member organizations and their communities and collaborates with many other organizations on specific causes of importance to the rare disease patient community. Visit rarediseases.org

About PlatformQ Health

PlatformQ Health Education is the leading provider of interactive digital medical education for clinicians, patients and caregivers. To improve patient care, PlatformQ Health Education creates video-first educational modules with premier partners, so learners can better understand conditions, available treatment options, and the latest research. The company’s proprietary platform allows participants to engage in real-time discussion with scientific, research and patient care experts – and the integrated learning solution enables advocates, administrators, health systems and plans, foundations, societies, member organizations and associations to measure the impact of their education.

Curis Digital – Digital Marketing For Healthcare Practices

In a time where precise messaging, strategic content and more dialed-in marketing tactics is needed more than ever. Curis Digital will provide that hands-on and enhanced level of service.

PHILADELPHIA (PRWEB)
July 13, 2020

Philadelphia Digital Marketing Powerhouse Media Components – Launches Curis Digital, a full-service Brand Strategy and Digital Marketing company focusing on HomeCare Agencies, Dental and Medical Spas and Aesthetic Practices. “Having an already robust portfolio of clients within the Greater Philadelphia area in these categories made our decision to expand services for their growing needs much easier,” said Denis Sinelnikov, President and Founder of Media Components. “In a time where precise messaging, strategic content and more dialed-in marketing tactics is needed more than ever. Curis Digital will provide that hands-on and enhanced level of service,” continued Sinelnikov.

Being an entrepreneur requires expertise, business savvy and a keen insight to grow an enterprise, but the reality is that the most intrepid and well-intentioned owners and doctors are typically expert in one thing – their own area of specialization. “Curis Digital is just the partner that every healthcare practitioner needs to identify their key market segments, engage them, then convert new business in today’s new marketplace,” said Rocco Iacobellis, Chief Marketing Officer of Curis. With a history of digital marketing experience to a variety of industries, Curis Digital was created from the legacy and continued success of its parent company Media Components who has been delivering full-service brand strategy and digital marketing solutions for over 20 years. Curis means healthcare in Latin and as such, the perfect defining name of this organization.

Today, healthcare practices can look to Curis Digital for brand strategy consulting, website development, social media, SEO|SEM, video production and expert content development. For more information about how Curis Digital can help your practice grow and profit, check us out at CurisDigital.com or contact us at (215) 396-3307. It’s never too late to gain a winning edge! We’ll get back to your inquiry as well on info@curisdigital.com

Company Social Media Links:

https://www.linkedin.com/company/curisdigital/

https://www.instagram.com/curisdigital/

https://www.facebook.com/curisdigital/

https://www.twitter.com/curisdigital/

Address:

Curis Digital

67 Buck Road

Huntingdon Valley, PA 19006

Share article on social media or email:

“Dexur’s value analysis tracks a patient’s episode of care from the date of admission for 90 days and includes the index hospitalization, rehospitalization, home health, nursing home, and ED costs.”

NEW YORK (PRWEB)
July 13, 2020

Dexur’s analysis of medicare claims of hospitals within a 50-mile radius of Portland, ME, showed that Mid Coast Hospital, Southern Maine Health Care, and Central Maine Medical Center had the best value outcomes over a 90-day episode for Sepsis. The episode of care tracks a patient journey from the date of admission for 90 days and includes the index hospitalizations, rehospitalization, home health, nursing home, and ED costs. The total cost of care data helps patients make appropriate choices and helps local ACOs such as MaineHealth Accountable Care Organization to make appropriate referrals choices. The analysis was risk-adjusted, for alive and non-hospice patients and was done at the DRG level, specifically DRG 871: Septicemia Or Severe Sepsis Without MV >96 Hours With Major Complication Or Comorbidity (MCC), to adjust for complications and comorbidities.

Mid Coast Hospital’s total cost of care over a 90 day episode was $22,526 (for the period between July 2016 and June 2019). The index hospitalization cost was $11,652 and the average rehospitalization cost per hospitalization was $5,798. The cost per rehospitalization was at an average of $19,668. Meanwhile, the average ED costs per hospitalization (when ED is involved) was $917.

The average home health cost per hospitalization when a home health agency is involved was $3,592. The average cost per hospitalization for the top home health agency partner for Sepsis for Mid Coast Hospital was:

Southern Maine Health Care’s total cost of care over a 90 day episode was $22,944 (for the period between July 2016 and June 2019). The index hospitalization cost was $11,339 and the average rehospitalization cost per hospitalization was $6,571. The cost per rehospitalization was at an average of $22,852. Meanwhile, the average ED costs per hospitalization (when ED is involved) was $847.

Central Maine Medical Center’s total cost of care over a 90 day episode was $23,263 (for the period between July 2016 and June 2019). The index hospitalization cost was $11,865 and the average rehospitalization cost per hospitalization was $6,460. The cost per rehospitalization was at an average of $20,487. Meanwhile, the average ED costs per hospitalization (when ED is involved) was $1,347.

Share article on social media or email:

Premier Mortgage Resources, LLC

“As a lender, we are in a unique position that allows us to directly ease the financial burden that so many are experiencing right now and, most importantly, we want to express our deep gratitude,” said PMR Managing Partner Cory Swain.

MERIDIAN, Idaho (PRWEB)
July 11, 2020

As a gesture of gratitude to local public safety professionals working on the front lines of the COVID-19 pandemic, Premier Mortgage Resources, LLC, has launched a new home loan savings program, called “Hometown Heroes.”

Under this program, any first responder or health care professional approved for a home loan through PMR will receive a closing cost credit. Qualifying borrowers are eligible for a credit of up to $1,295 toward the cost of closing their home loan from a waived documentation fee. If borrowers choose to work with a real estate agent who is participating in the program, they will receive an additional credit amount, determined by the agent.    

“As a lender, we are in a unique position that allows us to directly ease the financial burden that so many are experiencing right now and, most importantly, we want to express our deep gratitude,” said PMR Managing Partner, Cory Swain. “It’s such a privilege to be able to show our thanks to local heroes who are doing so much for the communities we lend in. We are truly in awe of the work they are doing.”

In addition to offering the program’s discount, loan officers are prepared to help health care professionals navigate the home loan process during this uncertain time. Homeowners are encouraged to contact a local branch to be put in touch with a loan officer who can assist with their unique financial situation.

“We know that the sacrifices being made by health care professionals are immeasurable, and we want to remove any barriers to homeownership that they may be experiencing so that they can focus on what matters most; the health and safety of themselves, their families and community members,” said Producing Branch Manager, Mandi Feely.

About Premier Mortgage Resources, LLC

PMR has been helping homebuyers achieve the dream of homeownership since 1991 and has grown to 31 branches throughout the United States, with a team of more than 120 loan officers ready to assist homebuyers in achieving their financial goals. The company prides itself on excellence in customer service, competitive rates and the best mortgage programs available. For more information about the Hometown Heroes program, visit PMRLoans.com.

Share article on social media or email: